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1 Introduction 
1.1 The impetus for developing a non-consensual genetic 
testing offence  
In 2003, the Australian Law Reform Commission (ALRC) and Australian 
Health Ethics Committee released its report, Essentially Yours: The Protection 
of Human Genetic Information in Australia, Report No 96.  The Inquiry 
focussed on issues arising out of the rapid development of human genetic 
technology.  The Inquiry was prompted by concerns about  
• privacy and discrimination, especially in the context of insurance and 
employment, and  
• ethical and other oversight of clinical practice, medical and scientific 
research, and the use and collection of genetic databases. 
Recommendation 12 of the ALRC’s report stated that: 
The Standing Committee of Attorneys-General (SCAG) should develop a 
model criminal offence relating to non-consensual genetic testing, for 
enactment into Commonwealth, state and territory law.  Criminal liability 
should attach to any individual or corporation that, without lawful authority, 
submits a sample for genetic testing, or conducts genetic testing on a sample, 
knowing (or recklessly indifferent to the fact) that the individual from whom the 
sample has been taken did not consent to such testing. 
In April 2007, SCAG requested that the Model Criminal Law Officers 
Committee (MCLOC) consider the merits of a draft model offence to 
criminalise non-consensual genetic testing.  SCAG asked MCLOC to give 
special consideration to health and law enforcement matters in developing the 
model offence. 
In this Discussion Paper, MCLOC examines the issue of non-consensual 
genetic testing and proposes draft model offences to criminalise it. 
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MCLOC encourages interested people or organisations to provide their views 
on this discussion paper.  These comments will be used to assist MCLOC in 
preparing its final report. 
Comments should be sent to: 
The MCLOC Secretariat 
Criminal Justice Division 
Attorney-General's Department 
Robert Garran Offices 
National Circuit 
BARTON  ACT  2600 
Fax:   02 6250 5918 
Email address: criminal.law@ag.gov.au  
 
Submissions will be published on the Commonwealth 
Attorney-General's Department website.  Please advise if you do not wish to 
have your submission published.  
1.2 Model Criminal Law Officers’ Committee 
On 28 June 1990, SCAG placed the question of the development of a national 
Model Criminal Code for Australian jurisdictions on its agenda.  To advance 
the concept, SCAG established the Criminal Law Officers Committee 
consisting of an officer from each Australian jurisdiction with expertise in 
criminal law and criminal justice matters.  That Committee’s name was 
changed in November 1993 to the Model Criminal Code Officers Committee 
(MCCOC).  MCCOC released several Discussion Papers and Reports on 
criminal law topics.1 
 
1 MCCOC and MCLOC discussion papers and reports can be found at the Australian 
Government Attorney-General's Department website at 
<http://www.ag.gov.au/www/agd/agd.nsf/Page/Model_criminal_code>. 
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In July 2006, SCAG decided to rename the committee as the Model Criminal 
Law Officers Committee to reflect the Committee’s broader role of advising on 
criminal law issues that have been referred to it by SCAG and the fact that 
development of the Model Criminal Code is largely complete. 
1.3 Committee’s previous work on related issues 
Non-consensual genetic testing may be captured by some theft and fraud 
offences.  The Committee has previously reported on the law dealing with 
these offences in its Final Report on Chapter 3: Theft, Fraud, Bribery and 
Related Offences (Dec 1995).  The Committee has also reported on model 
forensic procedures and non fatal offences against the person. 
2 What is non-consensual genetic testing? 
Non-consensual genetic testing occurs when bodily samples are taken and 
genetically tested without the knowledge or consent of the individual from 
whom they have been obtained.2  
Biomedical technology enables genetic testing to be performed on minute 
bodily samples.  Genetic information may be derived from samples such as 
hair follicles, saliva left on a glass or cigarette, cheek cells left on a toothbrush 
and cells deposited on an item of clothing or mucus in a tissue.3 
The combination of powerful biomedical technology and the ability to easily 
access human genetic samples leaves open the potential for non-consensual 
genetic testing to occur. 
 
 
2 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003, at paragraph 12.5. 
3 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.20. 
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3 What is the impact of non-consensual genetic 
testing? 
Paragraphs 12.12 to 12.14 of the ALRC Report outline the harm that 
non-consentual genetic testing can cause. 
12.12 The collection of a sample may, in some circumstances, involve a physical 
harm or a trespass to the person (a battery), as when a person is held down and a 
bodily sample is taken by force.  Collection may also result in emotional harm. 
Emotional harm may result from situations where, from the perspective of the 
individual concerned, intimate bodily samples (such as menstrual blood or semen) are 
taken, or kinship or identity is questioned.  
12.13 The most obvious harm arising from testing of the sample is the intrusion on 
basic human dignity and autonomy.  The harm may be also characterised as involving 
a breach of information privacy.  Genetic testing may result in the disclosure of 
sensitive personal information of many kinds.  Testing can reveal information about 
the present and future health of an individual, an individual’s identity, or his or her 
parentage or kinship.  The fact that harm may be caused by the non-consensual 
disclosure of these kinds of information is recognised by laws that proscribe 
disclosure in other contexts, including legal and statutory duties of confidentiality, 
and information and health privacy legislation.  
12.14 The possible uses of the information derived from non-consensual testing may 
also give rise to harm, including harm caused:  
•  by the use of genetic information by employers, insurers and others for 
discriminatory purposes;  
•  to individuals who involuntarily learn about their long-term health prognosis and 
other physical and behavioural characteristics, in breach of their ‘right not to know’;  
•  by media publicity about an individual’s genetic characteristics, especially where 
that individual is a celebrity or otherwise newsworthy;  
•  by the use of genetic information by police in criminal proceedings or by litigants 
in civil proceedings; and  
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•  by disruption to family relationships and harmony where parentage or other kinship 
information is disclosed.  
The ALRC Report also noted the increasingly common fear of ‘genetic trophy 
hunters’.  For example, bodyguards of former United States President, 
Bill Clinton, collected a pint glass after he had drunk from it in a British pub, to 
ensure that his DNA could not be obtained.  Newspapers have also reported a 
‘plot’ to obtain a sample of Prince Harry’s DNA.4 
4 Existing legislative framework 
 
The law in Australia offers some legal protection against harms arising out of 
non-consensual genetic testing.  These protections are outlined below.    
4.1 Tort of trespass to the person and assault  
The tort of trespass to the person is constituted by touching a person’s body 
without consent.  It is a civil tort which would need to be pursued through the 
courts.  Non-consensual touching may also constitute an assault in criminal 
law.   
The offence of assault and the tort of trespass would not apply in cases of 
‘discarded’ genetic material where a person has not been touched, such as 
hair from combs, saliva from a glass, cheek cells from a toothbrush, or mucus 
from a tissue.5 
Additionally, police and prosecutors may be reluctant to take action where the 
touching itself is minor, and no injury or harm is suffered. 
                                                 
4 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.6. 
5 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.20. 
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4.2 Theft and fraud 
As with assault and trespass, it is unlikely that police would investigate the 
apparently minor theft of a strand of hair or a blood stained tissue.  In the case 
of genetic data, it is the information that can be obtained from these items that 
raises real issues of concern.  Therefore, the relevant question is whether or 
not a person’s genetic information is ‘property capable of being stolen’.  
The ALRC noted that while current law recognises possessory rights and 
limited ownership interests in preserved samples of tissue, no proprietary 
rights are vested in the individual from whom samples are taken, such as 
might enable that individual to bring an action against others who deal with 
the samples.6 
In recent years, however, the definition of property has been expanded to 
cover intangible property, including things in action.  For example, the 
definition of property in South Australia’s Criminal Law Consolidation Act 1935 
includes ‘intangible property’ (including things in action).  
Intangible property describes something which a person or corporation can 
own and can transfer ownership of to another person or corporation, but has 
no physical substance.  It generally refers to statutory creations such as 
copyright, trademarks, and patents. 
A thing in action is an intangible personal property right recognised and 
protected by the law, but which has no existence apart from the recognition 
given by the law, or which confers no present possession of a tangible object.  
A chose in action, in its more limited meaning, denotes the right of enforcing 
the payment of a debt by legal proceedings, or obtaining money by way of 
damages for contract, or as a recompense for a wrong. 
Given these developments, information, and DNA information more 
specifically, may now fall within the definition of property, thereby making it 
capable of being stolen.   
 
6 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.21. 
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Similarly, many fraud offences have a wide application.  For example, the 
South Australian offence states:  
 
139—Deception 
A person who deceives another and, by doing so— 
(a) dishonestly benefits him/herself or a third person; or 
(b) dishonestly causes a detriment to the person subjected to the 
deception or a third person, is guilty of an offence. 
As with assault and trespass, these offences may have no application to 
discarded material, such as a glass in a public bar, where the person has 
willingly left the material behind or where there has been no deception of the 
person whose genetic material has been obtained. 
4.4  Breach of information privacy 
‘Information privacy’ can be defined as the right of an individual to control the 
collection, use and disclosure of information relating to him or her.7 
Privacy legislation at the Commonwealth, State and Territory levels provides 
some protection against the collection and testing of genetic samples without 
consent.  This protection is limited for the following reasons. 
(a) Genetic samples vs genetic information – except in New South Wales, 
information and health privacy legislation do not currently apply to 
genetic samples, in contrast with the genetic information derived from 
them.8  The Commonwealth Privacy Act 1988 (the Privacy Act) was 
amended in 2006 to extend the definition of ‘health information’ to 
include genetic information, and to extend the definition of ‘sensitive 
information’ to include genetic information that is not health information 
(for example the result of a parentage or kinship test).  The 
amendments do not extend to genetic samples because the then 
 
7 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003, at Chapter 7.  
8 Privacy and Personal Information Protection Act 1998 (NSW), section 4; Essentially Yours: 
The Protection of Human Genetic Information in Australia, ALRC Report No 96, 2003 at 
paragraph 12.22. 
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Commonwealth Government did not accept the ALRC’s 
recommendation (8-2) to amend the Privacy Act to regulate the 
handling of genetic samples.  Rather, it stated in its response to the 
ALRC response that: 
[t]he privacy principles are designed to regulate the collection, use and 
disclosure of personal information, not the source of that information.  
Accordingly, the Government does not consider that privacy legislation 
is the appropriate place for regulating genetic samples.  
 (b) Other than in the course of a business – the application of the 
Commonwealth Privacy Act is limited because acts done, or practices 
engaged in, by individuals are exempt if done or engaged in ‘other than 
in the course of a business carried on by the individual’.  The example 
of a journalist who sells information about Y’s genetic condition for a 
news story may be exempt under other provisions of the Privacy Act 
dealing specifically with media organisations and journalists.9   
There is also an exemption where the collection, use or disclosure of 
personal information occurs ‘only for the purposes of, or in connection 
with, his or her personal, family or household affairs’.10  This would 
exclude genetic testing for purposes relating to family health, personal 
identity or parentage testing.  
The ALRC considered that the Privacy Act is not the appropriate vehicle to 
prohibit non-consensual genetic testing.  It considered that the focus of the 
Privacy Act should remain on regulating the practices of government and 
businesses rather than individuals in their private capacities.  It also 
considered that the enforcement mechanisms for breach of the Privacy Act 
were inadequate sanction for non-consensual genetic testing.11 
 
9 Privacy Act 1988 (Cth) section 7B(4). 
10Privacy Act 1988 (Cth) section 16E. 
11Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.46. 
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4.5 Forensic procedures laws 
Non-consensual genetic testing is not unlawful under existing forensic 
procedures legislation.  These provisions typically set out when, where and 
how DNA testing can be conducted for criminal law purposes.   
Generally, non-consensual genetic testing is permitted only when an order by 
a relevant magistrate or judge has been obtained (for example, see Division 5 
of Part 1D of the Commonwealth Crimes Act 1914). 
4.6 New model offences: addressing the gaps in the existing 
legal framework 
After surveying the existing legal framework, MCLOC considers that the 
harms arising from non-consensual genetic testing are not addressed in 
Australia.   
MCLOC agrees with the ALRC’s comments that ‘a legislative response is 
required to address the gaps in existing legislation’.12  
5 Overseas responses  
5.1 United Kingdom 
The United Kingdom’s Human Genetics Commission reported on the issue of 
non-consensual genetic testing in its 2002 report, Inside Information: 
Balancing Interests in the Use of Personal Genetic Data.  The Commission 
concluded that there are scenarios where current legal remedies may not 
offer sufficient protection against breaches of an individual’s genetic privacy, 
for example in the following cases:13 
 
12 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.26. 
13 Human Genetics Commission, Inside Information: Balancing Interests in the Use of 
Personal Genetic Data, 2002, at page 60.  Cited in Essentially Yours: The Protection of 
Human Genetic Information in Australia, ALRC Report No 96, 2003 at paragraph 12.17.  
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• X takes Y’s beer glass and obtains an analysis of her DNA.  X then 
sells to a newspaper the information that Y has a particular genetic 
condition. 
• X decrypts anonymised genetic information about Y from a research 
study for some wrongful purpose.  
• X obtains a sample from child A, for whom he has no parental 
responsibility, to ascertain whether he is the father of A.  
The Commission recommended that  
consideration be given to the creation of a criminal offence of the non-
consensual or deceitful obtaining and/or analysis of personal genetic 
information for non-medical purposes.14  
 
The UK Government responded to this report in its White Paper on Genetics, 
Our Inheritance, Our Future: Realising the potential of genetics in the NHS.15  
It announced its intention to introduce a new offence of testing an individual’s 
DNA without his/her knowledge or consent.  It noted that new offences: 
• must not interfere with the use of genetic material by the police or the 
courts 
• must allow doctors or researchers to be sure whether they can order 
new genetic tests without returning to the patient for consent, and 
• must not affect lawful access to private paternity testing. 
 
 
14 Human Genetics Commission, Inside Information: Balancing Interests in the Use of 
Personal Genetic Data, 2002 at p 62. 
15 A copy of this report can be obtained at   
<http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidan
ce/DH_4006538>. 
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The offence of ‘DNA theft’ was implemented as part of the UK Human Tissue 
Act 2004.16  The offence in section 45 commenced on 1 September 2006 and 
provides that it is an offence to have any bodily material intending: 
• that any human DNA in the material be analysed without qualifying 
consent, and  
• that the results of the analysis be used otherwise than for an excepted 
purpose. 
 
The offence carries a maximum penalty of three years imprisonment.   
 
The definition of qualifying consent and excepted purposes are set out in 
Schedule 4.  Excepted purposes include general purposes such as medical 
treatment and criminal justice.  A copy of the text of section 45 and 
Schedule 4 Part 1 and 2 are at Attachment A.   
5.2 International Declaration on Human Genetic Data 
On 16 October 2003, the United Nations Educational, Scientific and Cultural 
Organization (UNESCO) adopted the International Declaration on Human 
Genetic Data.17  This recognised that human genetic data have a special 
status because: 
• they can be predictive of individual genetic predispositions 
• they may have a significant impact on the family, including offspring, 
extending over generations 
• they may contain information of a significance that is not necessarily 
known at the time of the collection of biological samples, and,  
• they may have cultural significance for persons or groups. 
 
 
16 A copy of this Act can be obtained at 
<http://www.opsi.gov.uk/ACTS/acts2004/ukpga_20040030_en_1>. 
17  A copy of this declaration can be obtained at 
<http://unesdoc.unesco.org/images/0013/001342/134217e.pdf>. 
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Relevant provisions of the Declaration are outlined below.  A complete copy of 
the Declaration is at Attachment B.  
 
• Article 1(c) provides that the Declaration applies to the collection, 
processing, use and storage of human genetic data … except in the 
investigation, detection and prosecution of criminal offences and in 
parentage testing that is subject to domestic law that is consistent with 
the international law of human rights 
• Article 7(a) provides that every effort should be made to ensure that 
human genetic data are not used for purposes that discriminate in a 
way that is intended to infringe, or has the effect of infringing human 
rights, fundamental freedoms or human dignity of an individual or for 
purposes that lead to the stigmatisation of an individual, a family, a 
group or communities 
• Article 8 requires that consent be obtained before any collection of 
human genetic data 
• Article 12 provides for the collection of biological samples for forensic 
medicine or in civil, criminal and other legal proceedings, and 
• Article 14 sets out privacy and confidentiality considerations. 
 
6 Model non-consensual genetic testing offences 
6.1 Conceptual framework  
As outlined above, the objective of the model offences is to address the 
harms arising out of non-consensual genetic testing.  The offences are not 
intended to: 
• override existing legislation and settled case law on consent and other 
relevant issues, or   
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• make unlawful currently lawful medical practices.  
The model provisions allow for the continued operation of existing legislation 
and case law where the law is settled.  For example, ‘consent’ is not defined 
in the model provisions because there is a settled body of case law about 
consent (both the physical contact and the conduct of medical procedures, 
including administering diagnostic and other tests) and how it is established 
(see discussion on section 5.3.2 for further information).   
The model provisions also provide a defence of lawful authority to protect 
currently lawful genetic testing practices (see discussion on section 5.3.5 for 
further information).  
6.2 The offenders 
The MCLOC model offences apply to individuals as well as bodies corporate 
that conduct the testing, such as laboratories and their employees, agents or 
officers.   
 
Where the offender is a body corporate, the physical elements of the offence 
would be attributed to the body corporate where committed by an employee, 
agent or officer acting within the actual or apparent scope of his/her 
employment, or within his or her actual or apparent authority.18   
 
The MCLOC model offences are aligned with the ALRC’s views about the 
application of the offences to individuals and bodies corporate. 
6.3 The model provisions  
MCLOC proposes draft model offences for consideration.  The proposed 
offences would form part of Chapter 5 (offences against the person) of the 
Model Criminal Code.  A complete version of the MCLOC model offences is 
set out at the end of this section. 
 
18 This is the approach adopted in sections 12.1 and 12.2 of the Criminal Code Act 1995 
(Cth); see discussion at Essentially Yours: The Protection of Human Genetic Information in 
Australia, ALRC Report No 96, 2003 at paragraph 12.55. 
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The MCCOC Forensic Procedures Report19 has been used as a model for 
drafting the non-consensual genetic testing provisions.  The offence, penalty 
provisions and defences for the proposed unlawful genetic testing offences 
are aligned with similar provisions in the Forensic Procedures Report.   
The model provisions apply standard fault elements used in Chapter 2 of the 
Model Criminal Code – the general principles of criminal responsibility.  The 
operation of the fault elements in each provision is explained below. 20  
Model provisions 
5.3.1 Definitions 
 
(1) In this Division: 
 
bodily material means any part of a human body or anything produced 
by a human body, including human organs, cells, ova and foetal tissue, 
hair, nails, skin tissue, saliva, blood, semen and other bodily fluids. 
 
genetic test means a test or procedure in which the bodily material of a 
person is used to reveal genetic information about that person. 
 
obtain bodily material includes remove or collect bodily material. 
 
(2) In this Division, a reference to bodily material of a person includes a 
reference to bodily material that no longer forms part of the person’s 
body but previously formed part of, or was produced by, the person’s 
body. 
 
(3) In this Division, a reference to a person incapable of giving consent is 
a reference to a living person who is: 
 
(a) a child under 18 years of age, or 
(b) incapable of understanding the general nature and effect of the action for 
which consent is required, or 
(c) incapable of indicating whether or not he or she consents or does not 
consent to the action for which consent is required. 
 
(4) In this Division, a reference to the consent of a person who is deceased 
is a reference to consent given (and not subsequently revoked) during the 
person’s lifetime. 
 
                                                 
19 MCCOC Report - Model Forensic Procedures Bill 2000 and the proposed national DNA 
database - May 1999. 
20 The standard Model Criminal Code fault elements are set out at the beginning of the 
MCCOC Report - Chapters 1 and 2 of the Model Criminal Code  The General Principles of 
Criminal Responsibility.     
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(5) In this Division, a reference to causing a genetic test to be conducted 
includes a reference to conducting a genetic test.  
 
5.3.2 Obtaining bodily material for genetic test 
 (1) A person who obtains any bodily material of another person: 
 
(a) with the intention of causing a genetic test to be conducted using that 
bodily material, and 
(b) without the consent to the genetic test of that other person, and 
(c) knowing about or being reckless as to that lack of consent,  
 
is guilty of an offence. 
 
Maximum penalty: Imprisonment for 2 years. 
 
(2) It is not an offence to attempt to commit an offence against this section. 
5.3.3 Use of bodily material for genetic test 
A person who causes a genetic test to be conducted using the bodily 
material of another person: 
 
(a) without the consent to the genetic test of that other person, and 
(b) knowing about that lack of consent, 
is guilty of an offence. 
Maximum penalty: Imprisonment for 2 years. 
 
5.3.4 Disclosure or use of results of genetic test 
 
(1) A person who discloses or uses any information obtained as a result of 
a genetic test conducted using the bodily material of another person: 
 
(a) without the consent of that other person to that disclosure or use, and 
(b) knowing about or being reckless as to that lack of consent,  
is guilty of an offence. 
 
Maximum penalty: Imprisonment for 2 years. 
 
(2) This section does not apply to the disclosure or use of information that 
does not identify any person. 
 
5.3.5 Application of offences if person incapable of giving consent 
 
A person who obtains or uses bodily material of a person who is incapable of 
giving consent at the time the bodily material is obtained or used, or discloses 
or uses information obtained as a result of a genetic test conducted using 
bodily material of a person who is incapable of giving consent at the time of 
the disclosure or use of the information: 
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(a) is to be treated as having acted without the consent of the person 
incapable of giving consent, and 
(b) is to be treated as having known about that lack of consent if it is proved 
that the person knew that the other person was, or was reckless as to the 
other person being, a person incapable of giving consent. 
 
5.3.6 Defences 
 
(1) A person is not criminally responsible for an offence against this Division in 
respect of the following: 
 
(a) the obtaining or use of any bodily material, or the disclosure or use of any 
information, if the person is a public official (within the meaning of Part 3.6) 
acting in the course of his or her duty as a police officer, prison officer or other 
law enforcement officer and the conduct of the person is reasonable in the 
circumstances for the purpose of performing that duty, 
 
(b) the disclosure or use of information in connection with proceedings for an 
offence or any legal proceedings arising out of a contravention of a law of the 
Commonwealth, a State or a Territory, 
 
(c) the obtaining or use of bodily material of a deceased person, or the 
disclosure or use of any information obtained as a result of a genetic test 
conducted using bodily material of a deceased person, if the person obtaining 
or using the bodily material or disclosing or using the information is 
[description of person or persons entitled to consent to testing of bodily 
material of deceased person] or is acting with the consent of that person, 
 
(d) the obtaining or use of bodily material of a person who is incapable of 
giving consent, or the disclosure or use of any information obtained as a result 
of a genetic test conducted using bodily material of a person who is incapable 
of giving consent, if the person is [description of person or persons entitled to 
consent to testing of bodily material on behalf of person incapable of giving 
consent] or is acting with the consent of that person. 
 
(2) This Division does not affect the obtaining or use of bodily material, or the 
disclosure or use of information obtained as a result of a genetic test 
conducted using bodily material, if the obtaining or use of the bodily material 
is authorised by or under another law of the State [or Territory] or a law of the 
Commonwealth. 
 
Note: It is for each jurisdiction to decide who is to be authorised to give 
consent to a genetic test, or to the disclosure or use of information about a 
genetic test, in the case of bodily material obtained from a deceased 
person or a person incapable of giving consent. This extends to the question 
of whether a genetic test using bodily material of a child must be consented to 
by one parent or by both parents and to the question of who should be able to 
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consent to the testing of bodily material of a deceased person if the deceased 
person cannot be identified. 
 
If a decision is made to require a parent (or both parents) to consent to a 
genetic test using bodily material of a child, section 5.1.8 of the Code 
contains a definition of “parent”. 
 
In the case of a bodily material of a deceased person, the person entitled to 
give consent could be defined in line with laws of the jurisdiction relating 
to donations of tissue or organs. For example, in NSW the legislation could 
enable the “senior available next of kin” (within the meaning of the Human 
Tissue Act 1983) to consent to a genetic test. 
 
Section 5.3.1 - Definitions  
 
(1) In this Division: 
 
bodily material means any part of a human body or anything produced 
by a human body, including human organs, cells, ova and foetal tissue, 
hair, nails, skin tissue, saliva, blood, semen and other bodily fluids. 
 
genetic test means a test or procedure in which the bodily material of a 
person is used to reveal genetic information about that person. 
 
obtain bodily material includes remove or collect bodily material. 
 
(2) In this Division, a reference to bodily material of a person includes a 
reference to bodily material that no longer forms part of the person’s 
body but previously formed part of, or was produced by, the person’s 
body. 
 
(3) In this Division, a reference to a person incapable of giving consent is 
a reference to a living person who is: 
(a) a child under 18 years of age, or 
(b) incapable of understanding the general nature and effect of the action for 
which consent is required, or 
(c) incapable of indicating whether or not he or she consents or does not 
consent to the action for which consent is required. 
 
(4) In this Division, a reference to the consent of a person who is deceased 
is a reference to consent given (and not subsequently revoked) during the 
person’s lifetime. 
 
(5) In this Division, a reference to causing a genetic test to be conducted 
includes a reference to conducting a genetic test.  
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Subsection 5.3.1(1) – definition of bodily material 
The definition of bodily material covers parts of a human body or anything 
produced by a human body.  This includes bodily material obtained from a 
deceased person.   
The three model offences apply to genetic testing conducted on the bodily 
material of deceased persons because the following harms could arise as a 
result of genetic testing on deceased persons: 
• revealing an illness with a genetic component, thus affecting surviving 
family members, and 
• revealing something that is embarrassing or damages the deceased’s 
reputation, causing distress to surviving family members. 
Subsection 5.3.1(1) – definition of genetic test 
MCLOC considers that ‘genetic test’ should be defined generally to be a test 
or procedure that uses bodily material of a person to reveal information about 
their genes.  The definition of genetic test does not list the tests described in 
the ALRC Report, 21 as the terms used in that definition are of a technical or 
scientific nature and are therefore at odds with the style of other provisions in 
the Model Criminal Code (which are capable of being generally understood).  
Also, the definition is technologically neutral because the types of genetic 
tests that can be undertaken are likely to change as technology develops.  
This definition captures all types of genetic testing, including testing of 
non-coding regions of DNA (this includes the Profiler Plus genetic testing 
system).    
 
21 Chapter 10 of the ALRC Report discusses forms of genetic testing, and defines genetic 
testing to be scientific tests that are conducted to reveal genetic information, including but not 
limited to DNA or RNA tests, tests using DNA chip technology, testing the biological products 
of particular genes, biochemical tests, medical imaging processes and assessments of 
morphological characteristics of certain cells.   
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Subsection 5.3.1 (2) 
This subsection provides that a reference to bodily material in the offence 
provisions includes bodily material obtained from the body of another person.  
When read with the other offence provisions, the effect of this section is that 
the requirement to obtain consent still applies in relation to testing bodily 
material that has become detached from a person’s body.  This will extend to 
cases in which the bodily material is mixed with the bodily material of another 
person.   
Subsection 5.3.1 (3) 
 
This subsection defines the categories of person who are 'incapable of giving 
consent'.  This term as defined then appears in section 5.3.5 which deals with 
how the concept of consent to a genetic test (which can render the offences 
inapplicable) operates in the case of such a person.  The listed categories of 
such people are: 
• children 
• people incapable of understanding the general nature and effect of the 
action for which consent is required 
• people incapable of indicating whether or not they consent to the 
action for which consent is required.  
Subsection 5.3.1(4) 
The subsection, read with the offence provisions, allows the deceased person 
to consent during their lifetime to the use of their bodily material or disclosure 
of genetic testing results once they have died.   
Subsection 5.3.1(5) 
This subsection defines the terms ‘causing a genetic test to be conducted’.  
Causing a genetic test to be conducted includes situations where a person  
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• conducts a genetic test themselves, or 
• arranges for genetic testing to occur through a third party (for example, 
by sending bodily material to a laboratory for testing).  
Section 5.3.2 - Obtaining bodily material for genetic test 
 
(1) A person who obtains any bodily material of another person: 
 
(a) with the intention of causing a genetic test to be conducted using that 
bodily material, and 
(b) without the consent to the genetic test of that other person, and 
(c) knowing about or being reckless as to that lack of consent,  
 
is guilty of an offence. 
 
Maximum penalty: Imprisonment for 2 years. 
 
(2) It is not an offence to attempt to commit an offence against section 5.3.2. 
This proposed offence criminalises the taking of bodily material for genetic 
testing when the person from whom bodily material has been obtained did not 
consent to having that specific sample of bodily material genetically tested. 
 
There are differing views about whether criminalising the taking of bodily 
material is appropriate.  The ALRC considered that criminalising the taking of 
the bodily material was inappropriate given the ubiquity of material from which 
genetic samples can be taken.22  However, the New South Wales Legal Aid 
Commission expressed the view, in a submission to the ALRC, that the 
conduct constituting the offence should include the taking of bodily material.23  
 
MCLOC considers both views can be addressed by criminalising the taking of 
bodily material where the intention of submitting it for genetic testing exists.  
By including the element of intention, a person cannot be charged for merely 
                                                 
22 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.52. 
23 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.50. 
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taking bodily material without the required consent.  MCLOC considers that 
this addresses the ALRC’s concern about the ubiquity of genetic samples. 
 
The United Kingdom has used intention in a similar way.  The UK ‘DNA theft’ 
offence is based on the possession of genetic material with intent to test that 
material.  That is, it is an offence to have any bodily material intending -  
       (a) that any human DNA in the material be analysed without qualifying 
consent, and  
       (b) that the results of the analysis be used otherwise than for an excepted 
purpose. 
 
Elements of the offence and penalty 
The fault elements24 and physical elements of the offence are outlined in the 
following table.  Under the Model Criminal Code 'default' fault elements are 
supplied where no fault element is specified.  These are indexed in the table 
below.25 
 
Offence Fault element Physical Penalty 
                                                 
24 Section 203 of the Model Criminal Code (found in Chapters 1 and 2 - The General 
Principles of Criminal Responsibility) defines the standard fault elements as follows.   
 
• A person has intention with respect to conduct when he or she means to engage in 
that conduct.  A person has intention with respect to circumstance when he or she 
believes that it exists or that it will exist.  A person has intention with respect to a 
result if he or she means to bring it about or is aware that it will occur in the ordinary 
course of events.   
 
• A person has knowledge of a circumstance or a result if he or she is aware that it 
exists or will exist in the ordinary course of events.   
 
• A person is reckless with respect to a circumstance if: 
(a) he or she is aware of a substantial risk that the circumstance exists or will exist, 
and 
(b) having regard to the circumstances known to him or her, it is unjustifiable to take 
the risk.  
 
25 Section 203.5 of the Model Criminal Code (found in Chapters 1 and 2 - The General 
Principles of Criminal Responsibility) provides that the default fault element under the Model 
Criminal Code is recklessness.    
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element 
A intends 
(means) to obtain 
the material. 
(default fault 
element) 
A obtains the 
material. 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that the 
material is bodily 
material. 
(default fault 
element) 
The material is 
bodily material. 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that the 
material belongs 
to B. 
(default fault 
element) 
The bodily 
material belongs 
to B. 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that B does 
not consent.  
The bodily 
material is 
obtained without 
the consent of B. 
Obtaining bodily 
material for 
genetic material 
testing 
A’s intention is to 
have the material 
genetically tested  
(ulterior fault 
element). 
N/A 
2 years 
 
The maximum penalty proposed for this offence is two years imprisonment.  
MCLOC considered this penalty reflects: 
• the seriousness of the harm to a victim’s personal autonomy, wellbeing 
and bodily integrity, and  
• the likelihood that the commission of the offence would result in 
long-term consequences for the victim’s family members and the 
general community.     
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Consent 
A physical element that appears in all three MCLOC model offences is that 
the individual from whom the bodily material was taken did not consent to 
such testing.   
 
Section 5.3.3 - Use of bodily material for genetic test 
A person who causes a genetic test to be conducted using the bodily 
material of another person: 
(a) without the consent to the genetic test of that other person, and 
(b) knowing about that lack of consent, 
is guilty of an offence. 
Maximum penalty: Imprisonment for 2 years. 
This proposed offence criminalises the use of bodily material for genetic 
testing when the person from whom bodily material has been obtained did not 
consent to having that specific sample of bodily material genetically tested. 
 
Elements of the offence and penalty 
The elements of the offence are outlined in the below table.  
Offence Fault element Physical 
element 
Penalty 
A intends 
(means) the test 
to be conducted. 
(default fault 
element) 
A causes a 
genetic test to be 
conducted 
A knows  (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that the 
material is bodily 
material. 
(default fault 
element) 
The test is 
conducted using 
bodily material. 
Use of bodily 
material for 
genetic testing 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
The bodily 
material belongs 
to B. 
2 years 
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risk) that the 
material belongs 
to B. 
(default fault 
element) 
A knows that B 
does not consent 
to the conduct of 
the test.  
B does not 
consent to the 
conduct of the 
test. 
 
The penalty is consistent with penalties assigned to similar offences.  For 
example, the Model Criminal Code offence of possession of identification 
information with the intention of committing an indictable offence carries a 
penalty of three years imprisonment.26 Similarly, the Health Records and 
Information Privacy Act 2002 (NSW) offence of the intentional disclosure or 
use of any health information about an individual carries a penalty of two 
years imprisonment.27 The MCLOC model offence is comparable in kind and 
seriousness to these offences – because they all result in a violation of an 
individual’s personal autonomy and privacy.   
Section 5.3.4 - Disclosure or use of results of genetic test 
(1) A person who discloses or uses any information obtained as a result of 
a genetic test conducted using the bodily material of another person: 
(a) without the consent of that other person to that disclosure or use, and 
(b) knowing about or being reckless as to that lack of consent,  
is guilty of an offence. 
 
Maximum penalty: Imprisonment for 2 years. 
 
(2) This section does not apply to the disclosure or use of information that 
does not identify any person. 
 
This proposed offence criminalises using or disclosing the results of another 
person’s genetic test, knowing about or being reckless as to whether that 
person has given consent to use the information for that purpose. 
MCLOC considers an offence of improper use or disclosure provides further 
protection to individuals by requiring genetic testing laboratories and other 
                                                 
26 Model Criminal Code section 6.3(3). 
27 Health Records and Information Privacy Act 2002 (NSW), section 68. 
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persons to obtain consent before using or disclosing information derived from 
a genetic test. 
Some submissions to the ALRC Inquiry, including from the South Australian 
Department of Human Services, submitted that the offending conduct should 
specifically include the ‘publication’ or ‘use’ of an identified individual’s 
results.28   
The ALRC pointed to the significant difficulties involved in defining the 
unauthorised uses, given the range of information that could be derived from 
samples and the spectrum of possible uses.  Some of these uses would be 
proscribed by existing law, such as where the publication of genetic 
information is defamatory.29   
The offence provision is restricted to the use and disclosure of genetic 
information that identifies the specific individual from whom the sample was 
obtained.  MCLOC considers that in many cases there may be benefits in 
allowing disclosure of genetic information that does not identify a person; for 
example, this may occur for the purposes of medical or scientific research; 
and that the potential harms in this are minimal. 
Proposed subsection (2) provides the offence does not apply to the disclosure 
or use of information that does not identify any person.    
Subsection (2) has been drafted in line with subsection 86(3) in the MCCOC 
Model Forensic Procedures Report. 30  Section 86 provides: 
 
86 Access to and disclosure of information on DNA 
identification databases (former cl 66B) 
 
(1) A person must not access, or disclose to any person, 
information stored on a DNA database unless the information 
 
28 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.51.  
29 Essentially Yours: The Protection of Human Genetic Information in Australia, ALRC Report 
No 96, 2003 at paragraph 12.53. 
30 MCCOC Report - Model Forensic Procedures Bill 2000 and the proposed national DNA 
database - May 1999. 
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is accessed or disclosed for one or more permissible 
purposes. 
 
Maximum penalty: 2 years imprisonment. 
… 
 
(3) Nothing in this section applies in relation to information that does 
not identify any person. 
 
Elements of the offence and penalty 
The elements of the offence are outlined in the below table.  
Offence Fault element Physical 
element 
Penalty 
A intends 
(means) to 
disclose or use 
the information. 
(default fault 
element) 
A discloses or 
uses information. 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that the 
information was 
obtained as a 
result of a genetic 
test. 
(default fault 
element) 
The information 
was obtained as 
a result of a 
genetic test. 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that the 
material is from 
B. 
(default fault 
element) 
The test was 
conducted on 
bodily material 
from B. 
Disclosure or use 
of results of 
genetic test 
A knows (is 
aware) or is 
reckless (aware 
of a substantial 
and unjustifiable 
risk) that B does 
not consent to the 
The information 
was disclosed or 
used without the 
consent of B. 
2 years 
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disclosure or use. 
Exception: The information does not identify any person.  
The disclosure offence in the draft is similar to the ‘disclosure of information’ 
offence in the MCCOC Model Forensic Procedures Report (section 81).  The 
disclosure of information offence carries a penalty of two years.  Accordingly, 
the penalty in the disclosure offence is aligned with the penalty of the 
disclosure of information offence. 
 
Section 5.3.5 - Application of offences if person incapable of giving 
consent  
 
A person who obtains or uses bodily material of a person who is incapable of 
giving consent at the time the bodily material is obtained or used, or discloses 
or uses information obtained as a result of a genetic test conducted using 
bodily material of a person who is incapable of giving consent at the time of 
the disclosure or use of the information: 
 
(a) is to be treated as having acted without the consent of the person 
incapable of giving consent, and 
(b) is to be treated as having known about that lack of consent if it is proved 
that the person knew that the other person was, or was reckless as to the 
other person being, a person incapable of giving consent. 
 
The genetic testing of bodily material taken from persons incapable of giving 
consent, and the disclosure of that information, is addressed in section 5.3.5.   
Section 5.3.5 is a deeming provision that applies to the offences in sections 
5.3.2-5.3.4. 
It governs how the exemptions from those offences relating to consent 
operate in the case of a person incapable of giving consent (as defined in 
subsection 5.3.1(3)).   
Only a person authorised to provide consent on their behalf (as provided by 
the relevant legislation) may do so.  The question of who may give consent on 
the behalf of a person incapable of giving consent has been left for each 
jurisdiction to determine.  
 
 
 
28
 
 
 
MCLOC recognises that in most jurisdictions, arrangements for determining 
who may consent on behalf of a person incapable of giving consent are dealt 
with by specific legislation or through a settled body of case law.  Generally, 
legislation and case law addresses the question of who may provide consent 
on behalf of a person incapable of giving consent for the following procedures: 
• the removal of tissue from the body 
• medical treatment, and 
• parentage testing.  
 
Human tissue legislation in most jurisdictions establishes how consent to the 
removal of tissue from the body is determined.  Section 7 of the Human 
Tissue Act 1983 (NSW), for instance, provides that an adult may consent to 
the removal of regenerative tissue for transplantation into another living 
person, therapeutic purposes, medical purposes, and scientific purposes.  
Section 10 provides that a parent may consent to the removal of regenerative 
tissue from a child if it is for certain purposes.  Similarly, section 7 of the 
Human Tissue Act 1982 (Vic) provides that an adult may consent to the 
removal of regenerative tissue for transplantation into another living person, 
therapeutic purposes, medical purposes, and scientific purposes.  Section 15 
of that Act provides that tissue is only to be removed from a child for the 
purposes of transplantation into the body of a parent, brother or sister.   
Guardianship legislation in most jurisdictions establishes the circumstances in 
which legal guardians may consent to the medical treatment of a person in 
their care.  For example, section 59 of the Guardianship and Administration 
Act 1993 (SA) provides a guardian may consent to the medical or dental 
treatment of a mentally incapacitated person.  Similarly, the Guardianship and 
Administration Act 1986 (Vic) provides that a ‘person responsible’ for a person 
may consent to medical treatment in section 39 of that Act.  A ‘person 
responsible’ is defined under section 37 of the Act.  
 
Issues of consent relating to parentage testing are determined under family 
law legislation in most jurisdictions.  For example, subsection 28(2) of the 
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Status of Children Act 1996 (NSW) deals with how consent is obtained when 
a court orders that parentage testing must be conducted on a person less 
than 18 years of age.  This section states that the procedure or act must not 
be carried out in relation to the child without the consent of a parent or 
guardian of the child.   
 
Similar provisions relating to consent in parentage testing can be found in 
Commonwealth, Tasmanian and Northern Territory legislation. 31 
 
Therefore, MCLOC considers that it would be inappropriate (and 
unnecessary) for the model non-consensual genetic testing offences to seek 
to regulate the means by which consent may be given on behalf of a person 
incapable of giving consent when established principles and precedents 
already exist in each jurisdiction.  The model offences are not intended to 
change existing consent principles.   MCLOC recommends that, for the 
purpose of the model offences, consent on behalf of a person incapable of 
giving consent should be established by: 
a) inserting provisions in the model offences which mirror existing 
legislation and common law that deals with consent in that jurisdiction, 
or 
b) amending existing legislative provisions that define consent in each 
jurisdiction to ensure these provisions extend to consent for genetic 
testing.  
 
Section 5.3.6 - Defences 
 
(1) A person is not criminally responsible for an offence against this Division in 
respect of the following: 
 
(a) the obtaining or use of any bodily material, or the disclosure or use of any 
information, if the person is a public official (within the meaning of Part 3.6) 
acting in the course of his or her duty as a police officer, prison officer or other 
law enforcement officer and the conduct of the person is reasonable in the 
circumstances for the purpose of performing that duty, 
 
                                                 
31 Family Law Act 1975 (Cth) section 69Z(2), Status of Children Act 1974 (TAS) section 15, 
and Status of Children Act (NT) section 13. 
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(b) the disclosure or use of information in connection with proceedings for an 
offence or any legal proceedings arising out of a contravention of a law of the 
Commonwealth, a State or a Territory, 
 
(c) the obtaining or use of bodily material of a deceased person, or the 
disclosure or use of any information obtained as a result of a genetic test 
conducted using bodily material of a deceased person, if the person obtaining 
or using the bodily material or disclosing or using the information is 
[description of person or persons entitled to consent to testing of bodily 
material of deceased person] or is acting with the consent of that person, 
 
(d) the obtaining or use of bodily material of a person who is incapable of 
giving consent, or the disclosure or use of any information obtained as a result 
of a genetic test conducted using bodily material of a person incapable of 
giving consent, if the person is [description of person or persons entitled to 
consent to testing of bodily material on behalf of person incapable of giving 
consent] or is acting with the consent of that person. 
 
(2) This Division does not affect the obtaining or use of bodily material, or the 
disclosure or use of information obtained as a result of a genetic test 
conducted using bodily material, if the obtaining or use of the bodily material 
is authorised by or under another law of the State [or Territory] or a law of the 
Commonwealth. 
MCLOC considers it important to limit the scope of the model offences by 
inserting defences that protect legitimate and accepted non-consensual 
genetic testing practices or the disclosure of genetic information.   
In framing the defences, MCLOC considered the issue of onus of proof.  The 
defences and the onus of proof issue are discussed below.   
Paragraph 5.3.6(1)(a) - defence for law enforcement activities 
 
It is important that the proposed offences not preclude lawful and legitimate 
law enforcement activities.  Accordingly, paragraph 5.3.6(1)(a) includes a 
defence applicable to 'reasonable conduct' by a police officer, prison or other 
law enforcement officer in the course of duty.  
 
At a minimum, the defence should apply to law enforcement conduct that is 
expressly authorised by law eg DNA testing powers under relevant legislation.  
Such conduct could be preserved simply by application of the lawful authority 
defence that forms part of the Model Criminal Code.  
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MCLOC lawful authority defence 
A person is not criminally responsible for an offence if the 
person’s conduct constituting the offence is justified or 
excused by any Act or law.32 
 
However, MCLOC has included a broader defence at paragraph 5.3.6(1)(a).  
That is because the lawful authority defence does not preserve the lawfulness 
of law enforcement conduct that would otherwise contravene the proposed 
genetic testing offences, and that is currently neither authorised nor prohibited 
by law.  Such conduct is currently lawful because there is no offence 
prohibiting it; however it would not be protected by the lawful authority 
defence because there is no law authorising it.  Depending on the jurisdiction, 
conduct falling into this grey area may include taking a crime scene sample or 
covertly obtaining genetic material. 
 
The effect of the proposed offences would be to outlaw such conduct, unless 
covered by a defence of the kind proposed.  An alternative approach would be 
for jurisdictions to legislatively authorise all law enforcement conduct relating 
to genetic material they viewed as legitimate, and to enact the narrower 'lawful 
authority' defence to apply where these laws provided authority.  
 
MCLOC has proposed a broad 'reasonable conduct' type of defence in a 
different context previously.  
 
MCLOC ‘reasonable conduct’ defence 
A person is not criminally responsible for an offence against 
this Part if the person is, at the time of the offence, a public 
official (within the meaning of Part 3.6) acting in the course of 
his or her duty as a police officer, prison officer, or other law 
 
32 Model Criminal Code – Chapter 5 Non Fatal Offences against the Person at page 138. 
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enforcement officer and the conduct of the person is 
reasonable in the circumstances of performing the duty.33  
 
MCLOC seeks comments on the merits of these two approaches.  
Paragraph 5.3.6(1)(b)   
MCLOC considers that it would be undesirable for the offences to apply to 
non-consensual genetic testing practices occurring in the context of legal 
proceedings.  
This paragraph provides a defence for the disclosure or use of information in 
connection with proceedings for an offence or any legal proceedings arising 
out of a contravention of a law of the Commonwealth, a State or Territory. 
Paragraph 5.3.6(1)(c)  
This paragraph provides a defence for situations where a person authorised 
to consent on behalf of a deceased person provided consent for  
• genetic testing of the bodily material of the deceased person or  
• the use or disclosure of results of genetic testing conducted on the 
deceased person.  
As discussed above, the definition of a person authorised to consent on 
behalf of a deceased person is to be determined under each jurisdiction’s 
existing arrangements.  
Paragraph 5.3.6(1)(d)  
This paragraph provides a defence for situations where a person authorised 
to consent on behalf of a person incapable of giving consent provided consent 
for  
• genetic testing of the bodily material of the person incapable of giving 
consent, or  
• the use or disclosure of results of genetic testing conducted on the 
person incapable of giving consent.  
 
33 Model Criminal Code – Chapter 5 Non Fatal Offences against the Person at page 138. 
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As discussed above, the definition of a person authorised to consent on 
behalf of a person incapable of giving consent is to be determined under each 
jurisdiction’s existing arrangements.  
Subsection 5.3.6(2) – the lawful authority defence 
MCLOC intends to protect currently lawful practices in the medical context 
through the defence of lawful authority.  A general defence of lawful authority 
is contained in Chapter 2 of the Model Criminal Code.34  The defence is set 
out below. 
Lawful authority 
A person is not criminally responsible for an offence if the person’s 
conduct constituting the offence is justified or excused by any Act 
or other law. 
A modified defence of lawful authority, adjusted to the non-consensual genetic 
testing context, is set out in subsection 5.3.5(2).    
The proposed lawful authority defence applies to genetic testing practices that 
are specifically authorised by existing legislation in Australian jurisdictions.  
For example, the Privacy Act was amended in 2006 to permit the disclosure of 
genetic information to a genetic relative where the disclosure is necessary to 
prevent a serious threat to the life, health or safety of that genetic relative.  
(National Privacy Principles 2.3(ea)). This disclosure would not be an offence 
under the proposed model offence provisions. 
However, in some cases, a genetic testing practice may currently be 
considered ‘legitimate’ but there may be no legislation actually authorising it.  
Persons engaging in unauthorised practices may be at risk of being charged 
under the model offence provisions, because the lawful excuse defence would 
not apply to these practices.  Therefore, before enacting the model offence 
provisions, States and Territories should review genetic testing practices that 
 
34 The lawful authority defence is set out at page 138 of Chapter 5 of the Model Criminal 
Code Report on Non Fatal Offences Against the Person.  In this Report, MCCOC proposed 
that the lawful authority defence should be added to Chapter 2 of the Code.  
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are not currently underpinned by legislative authority and consider whether 
these practices need to receive legislative support.   
MCLOC seeks comments from stakeholders/interested parties on activities 
that may be unintentionally caught by the model offences. 
Onus of Proof 
If the circumstances described in proposed section 5.3.6 (ie the defences) 
apply, the genetic testing offences in proposed sections 5.3.2 –5.3.4 will not 
be made out.  
 
A question for consideration is where the onus of proof should lie for 
establishing the absence of these matters.  As drafted, they are evidential 
burden defences.  The defendant must adduce some evidence to put the 
defence in issue, and then the onus passes to the prosecution to prove the 
absence of the defence as part of its case. 35 
   
An alternative approach would be to treat the absence of the matters in the 
defences as an element of the offence so that in every case, the prosecution 
must prove the absence of each of these matters as part of its case.   
 
MCLOC seeks comments on this alternative approach.  
 
 
 
 
 
 
 
35 Model Criminal Code – Chapters 1 and 2: The General Principles of Criminal Responsibility 
at page 114. 
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ATTACHMENT A 
 
UK ‘DNA Theft’ offence 
Human Tissue Act 2004 
45 Non-consensual analysis of DNA  
(1) A person commits an offence if—  
(a) he has any bodily material intending—  
(i) that any human DNA in the material be analysed without 
qualifying consent, and  
(ii) that the results of the analysis be used otherwise than for an 
excepted purpose,  
(b) the material is not of a kind excepted under subsection (2), and  
(c) he does not reasonably believe the material to be of a kind so 
excepted.  
 
(2) Bodily material is excepted if —  
(a) it is material which has come from the body of a person who died 
before the day on which this section comes into force and at least one 
hundred years have elapsed since the date of the person’s death,  
(b) it is an existing holding and the person who has it is not in 
possession, and not likely to come into possession, of information from 
which the individual from whose body the material has come can be 
identified, or  
(c) it is an embryo outside the human body.  
 
(3) A person guilty of an offence under this section—  
(a) is liable on summary conviction to a fine not exceeding the statutory 
maximum;  
(b) is liable on conviction on indictment—  
(i) to imprisonment for a term not exceeding 3 years, or  
(ii) to a fine, or  
(iii) to both.  
(4) Schedule 4 (which makes provision for the interpretation of “qualifying 
consent” and “use for an excepted purpose” in subsection (1)(a)) has effect.  
(5) In this section (and Schedule 4)—  
• “bodily material” means material which— 
(a) has come from a human body, and 
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(b) consists of or includes human cells; 
• “existing holding” means bodily material held immediately 
before the day on which this section comes into force. 
 
 
Section 45 
Introductory 
1 This Part of this Schedule makes provision for the interpretation of 
“qualifying consent” in section 45(1)(a)(i).  
Qualifying consent 
2 (1) In relation to analysis of DNA manufactured by the body of a person who 
is alive, “qualifying consent” means his consent, except where sub-paragraph 
(2) applies.  
(2) Where—  
(a) the person is a child,  
(b) neither a decision of his to consent, nor a decision of his not to consent, is 
in force, and  
(c) either he is not competent to deal with the issue of consent or, though he 
is competent to deal with that issue, he fails to do so,  
• “qualifying consent” means the consent of a person who has 
parental responsibility for him. 
(3) In relation to analysis of DNA manufactured by the body of a person who 
has died an adult, “qualifying consent” means—  
(a) if a decision of his to consent, or a decision of his not to consent, was in 
force immediately before he died, his consent;  
(b) if paragraph (a) does not apply, the consent of a person who stood in a 
qualifying relationship to him immediately before he died.  
(4) In relation to analysis of DNA manufactured by the body of a person who 
has died a child, “qualifying consent” means—  
(a) if a decision of his to consent, or a decision of his not to consent, was in 
force immediately before he died, his consent;  
(b) if paragraph (a) does not apply—  
(i) the consent of a person who had parental responsibility for him immediately 
before he died, or  
(ii) where no person had parental responsibility for him immediately before he 
died, the consent of a person who stood in a qualifying relationship to him at 
that time.  
Application to Scotland 
3 (1) In its application to Scotland, paragraph 2 has effect with the following 
amendments.  
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(2) In sub-paragraphs (2) and (4)(b)(i) and (ii), for “parental responsibility for” 
there is substituted “parental responsibilities in relation to”.  
(3) At the end there is inserted—  
“(5) In this paragraph—  
• “adult” means a person who has attained the age of 16 
years; 
• “child” means a person who has not attained the age of 16 
years; 
• “parental responsibilities” has the meaning given by section 
1(3) of the Children (Scotland) Act 1995 (c. 36).” 
PART 2 USE FOR AN EXCEPTED PURPOSE  
Introductory 
4 This Part of this Schedule makes provision for the interpretation of “use for 
an excepted purpose” in section 45(1)(a)(ii).  
Purposes of general application 
5 (1) Use of the results of an analysis of DNA for any of the following 
purposes is use for an excepted purpose—  
(a) the medical diagnosis or treatment of the person whose body 
manufactured the DNA;  
(b) purposes of functions of a coroner;  
(c) purposes of functions of a procurator fiscal in connection with the 
investigation of deaths;  
(d) the prevention or detection of crime;  
(e) the conduct of a prosecution;  
(f) purposes of national security;  
(g) implementing an order or direction of a court or tribunal, including one 
outside the United Kingdom.  
(2) For the purposes of sub-paragraph (1)(d), detecting crime shall be taken to 
include—  
(a) establishing by whom, for what purpose, by what means and generally in 
what circumstances any crime was committed, and  
(b) the apprehension of the person by whom any crime was committed;  
and the reference in sub-paragraph (1)(d) to the detection of crime includes 
any detection outside the United Kingdom of any crime or suspected crime. 
(3) In sub-paragraph (1)(e), the reference to a prosecution includes a 
prosecution brought in respect of a crime in a country or territory outside the 
United Kingdom.  
(4) In this paragraph, a reference to a crime includes a reference to any 
conduct which—  
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(a) constitutes one or more criminal offences (whether under the law of a part 
of the United Kingdom or a country or territory outside the United Kingdom),  
(b) is, or corresponds to, conduct which, if it all took place in any one part of 
the United Kingdom, would constitute one or more criminal offences, or  
(c) constitutes one or more offences of a kind triable by court-martial under 
the Army Act 1955 (3 & 4 Eliz. 2 c. 18), the Air Force Act 1955 (3 & 4 Eliz. 2 c. 
19) or the Naval Discipline Act 1957 (c. 53).  
(5) Sub-paragraph (1)(g) shall not be taken to confer any power to make 
orders or give directions.  
Purpose of research in connection with disorders, or functioning, of the human 
body 
6 (1) Use of the results of an analysis of DNA for the purpose of research in 
connection with disorders, or the functioning, of the human body is use for an 
excepted purpose if the bodily material concerned is the subject of an order 
under sub-paragraph (2).  
(2) The Secretary of State may by regulations specify circumstances in which 
the High Court or the Court of Session may order that this paragraph apply to 
bodily material.  
Purposes relating to existing holdings 
7 Use of the results of an analysis of DNA for any of the following purposes is 
use for an excepted purpose if the bodily material concerned is an existing 
holding—  
(a) clinical audit;  
(b) determining the cause of death;  
(c) education or training relating to human health;  
(d) establishing after a person’s death the efficacy of any drug or other 
treatment administered to him;  
(e) obtaining scientific or medical information about a living or deceased 
person which may be relevant to any other person (including a future person);  
(f) performance assessment;  
(g) public health monitoring;  
(h) quality assurance;  
(i) research in connection with disorders, or the functioning, of the human 
body;  
(j) transplantation.  
Purposes relating to material from body of a living person 
8 Use of the results of an analysis of DNA for any of the following purposes is 
use for an excepted purpose if the bodily material concerned is from the body 
of a living person—  
(a) clinical audit;  
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(b) education or training relating to human health;  
(c) performance assessment;  
(d) public health monitoring;  
(e) quality assurance.  
9 (1) Use of the results of an analysis of DNA for the purpose of obtaining 
scientific or medical information about the person whose body manufactured 
the DNA is use for an excepted purpose if—  
(a) the bodily material concerned is the subject of a direction under sub-
paragraph (2) or (3) or an order under sub-paragraph (4) or (5), and  
(b) the information may be relevant to the person for whose benefit the 
direction is given or order is made.  
(2) If the Authority is satisfied—  
(a) that bodily material has come from the body of a living person,  
(b) that it is not reasonably possible to trace the person from whose body the 
material has come (“the donor”),  
(c) that it is desirable in the interests of another person (including a future 
person) that DNA in the material be analysed for the purpose of obtaining 
scientific or medical information about the donor, and  
(d) that there is no reason to believe—  
(i) that the donor has died,  
(ii) that a decision of the donor to refuse consent to the use of the material for 
that purpose is in force, or  
(iii) that the donor lacks capacity to consent to the use of the material for that 
purpose,  
it may direct that this paragraph apply to the material for the benefit of the 
other person. 
(3) If the Authority is satisfied—  
(a) that bodily material has come from the body of a living person,  
(b) that it is desirable in the interests of another person (including a future 
person) that DNA in the material be analysed for the purpose of obtaining 
scientific or medical information about the person from whose body the 
material has come (“the donor”),  
(c) that reasonable efforts have been made to get the donor to decide whether 
to consent to the use of the material for that purpose,  
(d) that there is no reason to believe—  
(i) that the donor has died,  
(ii) that a decision of the donor to refuse to consent to the use of the material 
for that purpose is in force, or  
(iii) that the donor lacks capacity to consent to the use of the material for that 
purpose, and  
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(e) that the donor has been given notice of the application for the exercise of 
the power conferred by this sub-paragraph,  
it may direct that this paragraph apply to the material for the benefit of the 
other person. 
(4) If the Court of Session is satisfied—  
(a) that bodily material has come from the body of a living person,  
(b) that it is not reasonably possible to trace the person from whose body the 
material has come (“the donor”),  
(c) that it is desirable in the interests of another person (including a future 
person) that DNA in the material be analysed for the purpose of obtaining 
scientific or medical information about the donor, and  
(d) that there is no reason to believe—  
(i) that the donor has died,  
(ii) that a decision of the donor to refuse consent to the use of the material for 
that purpose is in force, or  
(iii) that the donor is an incapable adult within the meaning of the Adults with 
Incapacity (Scotland) Act 2000 (asp 4),  
it may order that this paragraph apply to the material for the benefit of the 
other person. 
(5) If the Court of Session is satisfied—  
(a) that bodily material has come from the body of a living person,  
(b) that it is desirable in the interests of another person (including a future 
person) that DNA in the material be analysed for the purpose of obtaining 
scientific or medical information about the person from whose body the 
material has come (“the donor”),  
(c) that reasonable efforts have been made to get the donor to decide whether 
to consent to the use of the material for that purpose,  
(d) that there is no reason to believe—  
(i) that the donor has died,  
(ii) that a decision of the donor to refuse to consent to the use of the material 
for that purpose is in force, or  
(iii) that the donor is an incapable adult within the meaning of the Adults with 
Incapacity (Scotland) Act 2000, and  
(e) that the donor has been given notice of the application for the exercise of 
the power conferred by this sub-paragraph,  
it may order that this paragraph apply to the material for the benefit of the 
other person. 
10 Use of the results of an analysis of DNA for the purpose of research in 
connection with disorders, or the functioning, of the human body is use for an 
excepted purpose if—  
 
 
41
 
 
 
(a) the bodily material concerned is from the body of a living person,  
(b) the research is ethically approved in accordance with regulations made by 
the Secretary of State, and  
(c) the analysis is to be carried out in circumstances such that the person 
carrying it out is not in possession, and not likely to come into possession, of 
information from which the individual from whose body the material has come 
can be identified.  
Purpose authorised under section 1 
11 Use of the results of an analysis of DNA for a purpose specified in 
paragraph 7 is use for an excepted purpose if the use in England and Wales, 
or Northern Ireland, for that purpose of the bodily material concerned is 
authorised by section 1(1) or (10)(c).  
Purposes relating to DNA of adults who lack capacity to consent 
12 (1) Use of the results of an analysis of DNA for a purpose specified under 
sub-paragraph (2) is use for an excepted purpose if—  
(a) the DNA has been manufactured by the body of a person who—  
(i) has attained the age of 18 years and, under the law of England and Wales 
or Northern Ireland, lacks capacity to consent to analysis of the DNA, or  
(ii) under the law of Scotland, is an adult with incapacity within the meaning of 
the Adults with Incapacity (Scotland) Act 2000 (asp 4), and  
(b) neither a decision of his to consent to analysis of the DNA for that 
purpose, nor a decision of his not to consent to analysis of it for that purpose, 
is in force.  
(2) The Secretary of State may by regulations specify for the purposes of this 
paragraph purposes for which DNA may be analysed.  
Power to amend paragraphs 5, 7 and 8 
13 The Secretary of State may by order amend paragraph 5, 7 or 8 for the 
purpose of—  
(a) varying or omitting any of the purposes specified in that paragraph, or  
(b) adding to the purposes so specified. 
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ATTACHMENT B 
 
 
International Declaration on Human Genetic Data 
 
16 October 2003 
 
The General Conference,  
 
Recalling the Universal Declaration of Human Rights of 10 December 1948, the two United 
Nations International Covenants on Economic, Social and Cultural Rights and on Civil and 
Political Rights of 16 December 1966, the United Nations International Convention on the 
Elimination of All Forms of Racial Discrimination of 21 December 1965, the United Nations 
Convention on the Elimination of All Forms of Discrimination against Women of 18 December 
1979, the United Nations Convention on the Rights of the Child of 20 November 1989, the 
United Nations Economic and Social Council resolutions 2001/39 on Genetic Privacy and 
Non-Discrimination of 26 July 2001 and 2003/232 on Genetic Privacy and Non-Discrimination 
of 22 July 2003, the ILO Convention (No. 111) concerning Discrimination in Respect of 
Employment and Occupation of 25 June 1958, the UNESCO Universal Declaration on 
Cultural Diversity of 2 November 2001, the Trade Related Aspects of Intellectual Property 
Rights Agreement (TRIPS) annexed to the Agreement establishing the World Trade 
Organization, which entered into force on 1 January 1995, the Doha Declaration on the 
TRIPS Agreement and Public Health of 14 November 2001 and the other international human 
rights instruments adopted by the United Nations and the specialized agencies of the United 
Nations system,  
 
Recalling more particularly the Universal Declaration on the Human Genome and Human 
Rights which it adopted, unanimously and by acclamation, on 11 November 1997 and which 
was endorsed by the United Nations General Assembly on 9 December 1998 and the 
Guidelines for the implementation of the Universal Declaration on the Human Genome and 
Human Rights which it endorsed on 16 November 1999 by 30 C/Resolution 23,  
 
Welcoming the broad public interest worldwide in the Universal Declaration on the Human 
Genome and Human Rights, the firm support it has received from the international community 
and its impact in Member States drawing upon it for their legislation, regulations, norms and 
standards, and ethical codes of conduct and guidelines,  
 
Bearing in mind the international and regional instruments, national laws, regulations and 
ethical texts relating to the protection of human rights and fundamental freedoms and to 
respect for human dignity as regards the collection, processing, use and storage of scientific 
data, as well as of medical data and personal data,  
 
Recognizing that genetic information is part of the overall spectrum of medical data and that 
the information content of any medical data, including genetic data and proteomic data, is 
highly contextual and dependent on the particular circumstances,  
 
Also recognizing that human genetic data have a special status on account of their sensitive 
nature since they can be predictive of genetic predispositions concerning individuals and that 
the power of predictability can be stronger than assessed at the time of deriving the data; they 
may have a significant impact on the family, including offspring, extending over generations, 
and in some instances on the whole group; they may contain information the significance of 
which is not necessarily known at the time of the collection of biological samples; and they 
may have cultural significance for persons or groups,  
 
Emphasizing that all medical data, including genetic data and proteomic data, regardless of 
their apparent information content, should be treated with the same high standards of 
confidentiality,  
 
Noting the increasing importance of human genetic data for economic and commercial 
purposes,  
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Having regard to the special needs and vulnerabilities of developing countries and the need 
to reinforce international cooperation in the field of human genetics,  
 
Considering that the collection, processing, use and storage of human genetic data are of 
paramount importance for the progress of life sciences and medicine, for their applications 
and for the use of such data for non-medical purposes,  
 
Also considering that the growing amount of personal data collected makes genuine 
irretrievability increasingly difficult,  
 
Aware that the collection, processing, use and storage of human genetic data have potential 
risks for the exercise and observance of human rights and fundamental freedoms and respect 
for human dignity,  
 
Noting that the interests and welfare of the individual should have priority over the rights and 
interests of society and research,  
 
Reaffirming the principles established in the Universal Declaration on the Human Genome 
and Human Rights and the principles of equality, justice, solidarity and responsibility as well 
as respect for human dignity, human rights and fundamental freedoms, particularly freedom of 
thought and expression, including freedom of research, and privacy and security of the 
person, which must underlie the collection, processing, use and storage of human genetic 
data,  
 
Proclaims the principles that follow and adopts the present Declaration.  
 
A. General provisions  
 
Article 1 – Aims and scope  
 
(a) The aims of this Declaration are: to ensure the respect of human dignity and protection of 
human rights and fundamental freedoms in the collection, processing, use and storage of 
human genetic data, human proteomic data and of the biological samples from which they are 
derived, referred to hereinafter as “biological samples”, in keeping with the requirements of 
equality, justice and solidarity, while giving due consideration to freedom of thought and 
expression, including freedom of research; to set out the principles which should guide States 
in the formulation of their legislation and their policies on these issues; and to form the basis 
for guidelines of good practices in these areas for the institutions and individuals concerned.  
 
(b) Any collection, processing, use and storage of human genetic data, human proteomic data 
and biological samples shall be consistent with the international law of human rights.  
 
(c) The provisions of this Declaration apply to the collection, processing, use and storage of 
human genetic data, human proteomic data and biological samples, except in the 
investigation, detection and prosecution of criminal offences and in parentage testing that are 
subject to domestic law that is consistent with the international law of human rights.  
 
Article 2 – Use of terms  
 
For the purposes of this Declaration, the terms used have the following meanings:  
 
(i) Human genetic data: Information about heritable characteristics of individuals obtained by 
analysis of nucleic acids or by other scientific analysis;  
 
(ii) Human proteomic data: Information pertaining to an individual’s proteins including their 
expression, modification and interaction;  
 
(iii) Consent: Any freely given specific, informed and express agreement of an individual to his 
or her genetic data being collected, processed, used and stored;  
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(iv) Biological samples: Any sample of biological material (for example blood, skin and bone 
cells or blood plasma) in which nucleic acids are present and which contains the 
characteristic genetic make-up of an individual;  
 
(v) Population-based genetic study: A study which aims at understanding the nature and 
extent of genetic variation among a population or individuals within a group or between 
individuals across different groups;  
 
(vi) Behavioural genetic study: A study that aims at establishing possible connections 
between genetic characteristics and behaviour;  
 
(vii) Invasive procedure: Biological sampling using a method involving intrusion into the 
human body, such as obtaining a blood sample by using a needle and syringe;  
 
(viii) Non-invasive procedure: Biological sampling using a method which does not involve 
intrusion into the human body, such as oral smears;  
 
(ix) Data linked to an identifiable person: Data that contain information, such as name, birth 
date and address, by which the person from whom the data were derived can be identified;  
 
(x) Data unlinked to an identifiable person: Data that are not linked to an identifiable person, 
through the replacement of, or separation from, all identifying information about that person 
by use of a code;  
 
(xi) Data irretrievably unlinked to an identifiable person: Data that cannot be linked to an 
identifiable person, through destruction of the link to any identifying information about the 
person who provided the sample;  
 
(xii) Genetic testing: A procedure to detect the presence or absence of, or change in, a 
particular gene or chromosome, including an indirect test for a gene product or other specific 
metabolite that is primarily indicative of a specific genetic change;  
 
(xiii) Genetic screening: Large-scale systematic genetic testing offered in a programme to a 
population or subsection thereof intended to detect genetic characteristics in asymptomatic 
people;  
 
(xiv) Genetic counselling: A procedure to explain the possible implications of the findings of 
genetic testing or screening, its advantages and risks and where applicable to assist the 
individual in the long-term handling of the consequences; It takes place before and after 
genetic testing and screening;  
 
(xv) Cross-matching: Matching of information about an individual or a group contained in 
various data files set up for different purposes.  
 
Article 3 – Person’s identity  
 
Each individual has a characteristic genetic make-up. Nevertheless, a person’s identity should 
not be reduced to genetic characteristics, since it involves complex educational, 
environmental and personal factors and emotional, social, spiritual and cultural bonds with 
others and implies a dimension of freedom.  
 
Article 4 – Special status  
 
(a) Human genetic data have a special status because:  
 
(i) they can be predictive of genetic predispositions concerning individuals;  
 
(ii) they may have a significant impact on the family, including offspring, extending over 
generations, and in some instances on the whole group to which the person concerned 
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belongs;  
 
(iii) they may contain information the significance of which is not necessarily known at the 
time of the collection of the biological samples;  
 
(iv) they may have cultural significance for persons or groups.  
 
(b) Due consideration should be given to the sensitivity of human genetic data and an 
appropriate level of protection for these data and biological samples should be established.  
 
Article 5 – Purposes  
 
Human genetic data and human proteomic data may be collected, processed, used and 
stored only for the purposes of:  
 
(i) diagnosis and health care, including screening and predictive testing;  
 
(ii) medical and other scientific research, including epidemiological, especially population-
based genetic studies, as well as anthropological or archaeological studies, collectively 
referred to hereinafter as “medical and scientific research”;  
 
(iii) forensic medicine and civil, criminal and other legal proceedings, taking into account the 
provisions of Article 1(c);  
 
(iv) or any other purpose consistent with the Universal Declaration on the Human Genome 
and Human Rights and the international law of human rights.  
 
Article 6 – Procedures  
 
(a) It is ethically imperative that human genetic data and human proteomic data be collected, 
processed, used and stored on the basis of transparent and ethically acceptable procedures. 
States should endeavour to involve society at large in the decision-making process 
concerning broad policies for the collection, processing, use and storage of human genetic 
data and human proteomic data and the evaluation of their management, in particular in the 
case of population-based genetic studies. This decision-making process, which may benefit 
from international experience, should ensure the free expression of various viewpoints.  
 
(b) Independent, multidisciplinary and pluralist ethics committees should be promoted and 
established at national, regional, local or institutional levels, in accordance with the provisions 
of Article 16 of the Universal Declaration on the Human Genome and Human Rights. Where 
appropriate, ethics committees at national level should be consulted with regard to the 
establishment of standards, regulations and guidelines for the collection, processing, use and 
storage of human genetic data, human proteomic data and biological samples. They should 
also be consulted concerning matters where there is no domestic law. Ethics committees at 
institutional or local levels should be consulted with regard to their application to specific 
research projects.  
 
(c) When the collection, processing, use and storage of human genetic data, human 
proteomic data or biological samples are carried out in two or more States, the ethics 
committees in the States concerned, where appropriate, should be consulted and the review 
of these questions at the appropriate level should be based on the principles set out in this 
Declaration and on the ethical and legal standards adopted by the States concerned.  
 
(d) It is ethically imperative that clear, balanced, adequate and appropriate information shall 
be provided to the person whose prior, free, informed and express consent is sought. Such 
information shall, alongside with providing other necessary details, specify the purpose for 
which human genetic data and human proteomic data are being derived from biological 
samples, and are used and stored. This information should indicate, if necessary, risks and 
consequences. This information should also indicate that the person concerned can withdraw 
his or her consent, without coercion, and this should entail neither a disadvantage nor a 
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penalty for the person concerned.  
 
Article 7 – Non-discrimination and non-stigmatization  
 
(a) Every effort should be made to ensure that human genetic data and human proteomic 
data are not used for purposes that discriminate in a way that is intended to infringe, or has 
the effect of infringing human rights, fundamental freedoms or human dignity of an individual 
or for purposes that lead to the stigmatization of an individual, a family, a group or 
communities.  
 
(b) In this regard, appropriate attention should be paid to the findings of population-based 
genetic studies and behavioural genetic studies and their interpretations.  
 
B. Collection  
 
Article 8 – Consent  
 
(a) Prior, free, informed and express consent, without inducement by financial or other 
personal gain, should be obtained for the collection of human genetic data, human proteomic 
data or biological samples, whether through invasive or non-invasive procedures, and for their 
subsequent processing, use and storage, whether carried out by public or private institutions. 
Limitations on this principle of consent should only be prescribed for compelling reasons by 
domestic law consistent with the international law of human rights.  
 
(b) When, in accordance with domestic law, a person is incapable of giving informed consent, 
authorization should be obtained from the legal representative, in accordance with domestic 
law. The legal representative should have regard to the best interest of the person concerned.  
 
(c) An adult not able to consent should as far as possible take part in the authorization 
procedure. The opinion of a minor should be taken into consideration as an increasingly 
determining factor in proportion to age and degree of maturity.  
 
(d) In diagnosis and health care, genetic screening and testing of minors and adults not able 
to consent will normally only be ethically acceptable when they have important implications for 
the health of the person and have regard to his or her best interest.  
 
Article 9 – Withdrawal of consent  
 
(a) When human genetic data, human proteomic data or biological samples are collected for 
medical and scientific research purposes, consent may be withdrawn by the person 
concerned unless such data are irretrievably unlinked to an identifiable person. In accordance 
with the provisions of Article 6(d), withdrawal of consent should entail neither a disadvantage 
nor a penalty for the person concerned.  
 
(b) When a person withdraws consent, the person’s genetic data, proteomic data and 
biological samples should no longer be used unless they are irretrievably unlinked to the 
person concerned.  
 
(c) If not irretrievably unlinked, the data and biological samples should be dealt with in 
accordance with the wishes of the person. If the person’s wishes cannot be determined or are 
not feasible or are unsafe, the data and biological samples should either be irretrievably 
unlinked or destroyed.  
 
Article 10 – The right to decide whether or not to be informed about research results  
 
When human genetic data, human proteomic data or biological samples are collected for 
medical and scientific research purposes, the information provided at the time of consent 
should indicate that the person concerned has the right to decide whether or not to be 
informed of the results. This does not apply to research on data irretrievably unlinked to 
identifiable persons or to data that do not lead to individual findings concerning the persons 
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who have participated in such a research. Where appropriate, the right not to be informed 
should be extended to identified relatives who may be affected by the results.  
 
Article 11 – Genetic counselling  
 
It is ethically imperative that when genetic testing that may have significant implications for a 
person’s health is being considered, genetic counselling should be made available in an 
appropriate manner. Genetic counselling should be non-directive, culturally adapted and 
consistent with the best interest of the person concerned.  
 
Article 12 – Collection of biological samples for forensic medicine or in civil, criminal 
and other legal proceedings  
 
When human genetic data or human proteomic data are collected for the purposes of forensic 
medicine or in civil, criminal and other legal proceedings, including parentage testing, the 
collection of biological samples, in vivo or post-mortem, should be made only in accordance 
with domestic law consistent with the international law of human rights.  
 
C. Processing  
 
Article 13 – Access  
 
No one should be denied access to his or her own genetic data or proteomic data unless such 
data are irretrievably unlinked to that person as the identifiable source or unless domestic law 
limits such access in the interest of public health, public order or national security.  
 
Article 14 – Privacy and confidentiality  
 
(a) States should endeavour to protect the privacy of individuals and the confidentiality of 
human genetic data linked to an identifiable person, family or, where appropriate, group, in 
accordance with domestic law consistent with the international law of human rights.  
 
(b) Human genetic data, human proteomic data and biological samples linked to an 
identifiable person should not be disclosed or made accessible to third parties, in particular, 
employers, insurance companies, educational institutions and the family, except for an 
important public interest reason in cases restrictively provided for by domestic law consistent 
with the international law of human rights or where the prior, free, informed and express 
consent of the person concerned has been obtained provided that such consent is in 
accordance with domestic law and the international law of human rights. The privacy of an 
individual participating in a study using human genetic data, human proteomic data or 
biological samples should be protected and the data should be treated as confidential.  
 
(c) Human genetic data, human proteomic data and biological samples collected for the 
purposes of scientific research should not normally be linked to an identifiable person. Even 
when such data or biological samples are unlinked to an identifiable person, the necessary 
precautions should be taken to ensure the security of the data or biological samples.  
 
(d) Human genetic data, human proteomic data and biological samples collected for medical 
and scientific research purposes can remain linked to an identifiable person, only if necessary 
to carry out the research and provided that the privacy of the individual and the confidentiality 
of the data or biological samples concerned are protected in accordance with domestic law.  
 
(e) Human genetic data and human proteomic data should not be kept in a form which allows 
the data subject to be identified for any longer than is necessary for achieving the purposes 
for which they were collected or subsequently processed.  
 
Article 15 – Accuracy, reliability, quality and security  
 
The persons and entities responsible for the processing of human genetic data, human 
proteomic data and biological samples should take the necessary measures to ensure the 
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accuracy, reliability, quality and security of these data and the processing of biological 
samples. They should exercise rigour, caution, honesty and integrity in the processing and 
interpretation of human genetic data, human proteomic data or biological samples, in view of 
their ethical, legal and social implications.  
 
D. Use  
 
Article 16 – Change of purpose  
 
(a) Human genetic data, human proteomic data and the biological samples collected for one 
of the purposes set out in Article 5 should not be used for a different purpose that is 
incompatible with the original consent, unless the prior, free, informed and express consent of 
the person concerned is obtained according to the provisions of Article 8(a) or unless the 
proposed use, decided by domestic law, corresponds to an important public interest reason 
and is consistent with the international law of human rights. If the person concerned lacks the 
capacity to consent, the provisions of Article 8(b) and (c) should apply mutatis mutandis.  
 
(b) When prior, free, informed and express consent cannot be obtained or in the case of data 
irretrievably unlinked to an identifiable person, human genetic data may be used in 
accordance with domestic law or following the consultation procedures set out in Article 6(b).  
 
Article 17 – Stored biological samples  
 
(a) Stored biological samples collected for purposes other than set out in Article 5 may be 
used to produce human genetic data or human proteomic data with the prior, free, informed 
and express consent of the person concerned. However, domestic law may provide that if 
such data have significance for medical and scientific research purposes e.g. epidemiological 
studies, or public health purposes, they may be used for those purposes, following the 
consultation procedures set out in Article 6(b).  
 
(b) The provisions of Article 12 should apply mutatis mutandis to stored biological samples 
used to produce human genetic data for forensic medicine.  
 
Article 18 – Circulation and international cooperation  
 
(a) States should regulate, in accordance with their domestic law and international 
agreements, the cross-border flow of human genetic data, human proteomic data and 
biological samples so as to foster international medical and scientific cooperation and ensure 
fair access to these data. Such a system should seek to ensure that the receiving party 
provides adequate protection in accordance with the principles set out in this Declaration.  
 
(b) States should make every effort, with due and appropriate regard for the principles set out 
in this Declaration, to continue fostering the international dissemination of scientific 
knowledge concerning human genetic data and human proteomic data and, in that regard, to 
foster scientific and cultural cooperation, particularly between industrialized and developing 
countries.  
 
(c) Researchers should endeavour to establish cooperative relationships, based on mutual 
respect with regard to scientific and ethical matters and, subject to the provisions of Article 14, 
should encourage the free circulation of human genetic data and human proteomic data in 
order to foster the sharing of scientific knowledge, provided that the principles set out in this 
Declaration are observed by the parties concerned. To this end, they should also endeavour 
to publish in due course the results of their research.  
 
Article 19 – Sharing of benefits  
 
(a) In accordance with domestic law or policy and international agreements, benefits resulting 
from the use of human genetic data, human proteomic data or biological samples collected for 
medical and scientific research should be shared with the society as a whole and the 
international community. In giving effect to this principle, benefits may take any of the 
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following forms:  
 
(i) special assistance to the persons and groups that have taken part in the research;  
 
(ii) access to medical care;  
 
(iii) provision of new diagnostics, facilities for new treatments or drugs stemming from the 
research;  
 
(iv) support for health services;  
 
(v) capacity-building facilities for research purposes;  
 
(vi) development and strengthening of the capacity of developing countries to collect and 
process human genetic data, taking into consideration their specific problems;  
 
(vii) any other form consistent with the principles set out in this Declaration.  
 
(b) Limitations in this respect could be provided by domestic law and international 
agreements.  
 
E. Storage  
 
Article 20 – Monitoring and management framework  
 
States may consider establishing a framework for the monitoring and management of human 
genetic data, human proteomic data and biological samples based on the principles of 
independence, multidisciplinarity, pluralism and transparency as well as the principles set out 
in this Declaration. This framework could also deal with the nature and purposes of the 
storage of these data.  
 
Article 21 – Destruction  
 
(a) The provisions of Article 9 apply mutatis mutandis in the case of stored human genetic 
data, human proteomic data and biological samples.  
 
(b) Human genetic data, human proteomic data and the biological samples collected from a 
suspect in the course of a criminal investigation should be destroyed when they are no longer 
necessary, unless otherwise provided for by domestic law consistent with the international law 
of human rights.  
 
(c) Human genetic data, human proteomic data and biological samples should be available 
for forensic purposes and civil proceedings only for as long as they are necessary for those 
proceedings, unless otherwise provided for by domestic law consistent with the international 
law of human rights.  
 
Article 22 – Cross-matching  
 
Consent should be essential for the cross-matching of human genetic data, human proteomic 
data or biological samples stored for diagnostic and health care purposes and for medical and 
other scientific research purposes, unless otherwise provided for by domestic law for 
compelling reasons and consistent with the international law of human rights.  
 
F. Promotion and implementation  
 
Article 23 – Implementation  
 
(a) States should take all appropriate measures, whether of a legislative, administrative or 
other character, to give effect to the principles set out in this Declaration, in accordance with 
the international law of human rights. Such measures should be supported by action in the 
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sphere of education, training and public information.  
 
(b) In the framework of international cooperation, States should endeavour to enter into 
bilateral and multilateral agreements enabling developing countries to build up their capacity 
to participate in generating and sharing scientific knowledge concerning human genetic data 
and the related know-how.  
 
Article 24 – Ethics education, training and information  
 
In order to promote the principles set out in this Declaration, States should endeavour to 
foster all forms of ethics education and training at all levels as well as to encourage 
information and knowledge dissemination programmes about human genetic data. These 
measures should aim at specific audiences, in particular researchers and members of ethics 
committees, or be addressed to the public at large. In this regard, States should encourage 
the participation of international and regional intergovernmental organizations and 
international, regional and national non-governmental organizations in this endeavour.  
 
Article 25 – Roles of the International Bioethics Committee (IBC) and the 
Intergovernmental Bioethics Committee (IGBC)  
 
The International Bioethics Committee (IBC) and the Intergovernmental Bioethics Committee 
(IGBC) shall contribute to the implementation of this Declaration and the dissemination of the 
principles set out therein. On a collaborative basis, the two Committees should be responsible 
for its monitoring and for the evaluation of its implementation, inter alia, on the basis of reports 
provided by States. The two Committees should be responsible in particular for the 
formulation of any opinion or proposal likely to further the effectiveness of this Declaration. 
They should make recommendations in accordance with UNESCO’s statutory procedures, 
addressed to the General Conference.  
 
Article 26 – Follow-up action by UNESCO  
 
UNESCO shall take appropriate action to follow up this Declaration so as to foster progress of 
the life sciences and their applications through technologies, based on respect for human 
dignity and the exercise and observance of human rights and fundamental freedoms.  
 
Article 27 – Denial of acts contrary to human rights, fundamental freedoms and human 
dignity  
Nothing in this Declaration may be interpreted as implying for any State, group or person any 
claim to engage in any activity or to perform any act contrary to human rights, fundamental 
freedoms and human dignity, including, in particular, the principles set out in this Declaration. 
 
 
 
 
 
 
 
